Antibody Characterization Report for E3 ubiquitin-protein ligase parkin (Parkin)

Head-to-head comparison of available commercial antibodies against E3 ubiquitin-protein ligase parkin (Parkin) by immunoblot (Western blot), immunoprecipitation and immunofluorescence.

The following study was funded in part by Genome Québec's Genomics Integration Program, awarded to the research laboratory of Peter S. McPherson. This work was supported in part by the Michael J. Fox Foundation for Parkinson's research.